Ocugen, Inc. (OCGN) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	4.6M	4.4M	4.1M	6.0M	2.5M
Cost of Revenue	—	2.4M	2.0M	704.0K	—
Gross Profit	4.6M	2.0M	2.1M	5.3M	2.5M
Operating Expenses
R&D Expense	43.8M	39.8M	32.1M	39.6M	56.2M
SG&A Expense	29.7M	27.6M	26.7M	32.0M	35.4M
General & Admin Expense	29.7M	27.6M	26.7M	32.0M	35.4M
Selling & Marketing Expense	—	—	—	—	—
Other Expenses	—	(2.4M)	(2.0M)	(704.0K)	—
Total Operating Expenses	73.5M	64.9M	56.8M	70.9M	91.6M
Cost and Expenses	73.5M	67.3M	58.8M	71.6M	91.6M
Operating Income (EBIT)	(68.9M)	(62.9M)	(54.8M)	(65.5M)	(89.1M)
Non-Operating
Interest Income	878.0K	922.0K	1.3M	2.5M	1.4M
Interest Expense	8.4M	5.2M	—	—	—
Net Interest Income	(7.6M)	(4.3M)	1.3M	2.5M	1.4M
Other Non-Op Income/Expense	(12.9M)	(4.9M)	703.0K	2.5M	2.3M
Non-Operating Income (excl Interest)	3.9M	(258.0K)	(703.0K)	(2.5M)	(2.3M)
EBT (Pre-Tax Income)	(81.8M)	(67.8M)	(54.1M)	(63.1M)	(86.8M)
Income Tax Expense	—	—	—	—	—
Bottom Line
Net Income	(81.8M)	(67.8M)	(54.1M)	(63.1M)	(86.8M)
Earnings from Cont. Ops	(81.8M)	(67.8M)	(54.1M)	(63.1M)	(86.8M)
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	(81.8M)	(67.8M)	(54.1M)	(63.1M)	(86.8M)
Per Share
Basic EPS	($0.25)	($0.23)	($0.20)	($0.26)	($0.40)
Diluted EPS	($0.25)	($0.23)	($0.20)	($0.26)	($0.40)
Revenue Per Share	$0.01	$0.01	$0.01	$0.02	$0.01
Shares
Basic Shares Outstanding	338.7M	300.2M	271.0M	244.3M	214.6M
Diluted Shares Outstanding	338.7M	300.2M	271.0M	244.3M	214.6M
Profitability Metrics
EBITDA	(70.1M)	(60.3M)	(52.1M)	(62.4M)	(86.3M)
D&A	2.7M	2.4M	2.0M	704.0K	480.0K
EBIT	(72.8M)	(62.7M)	(54.1M)	(63.1M)	(86.8M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026